In particular, hypoxic GBM-derived exosomes carrying VEGF-A enhance blood–brain barrier (BBB) permeability by specifically altering the expression of claudin-5 and occludin in ECs, in both in vitro and in vivo GBM models [108]. This evidence concerns the gene CLDN5 and glioblastoma.